Cellectar Biosciences (CLRB)
(Delayed Data from NSDQ)
$2.12 USD
+0.03 (1.44%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.11 -0.01 (-0.47%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: BMO |
6/2024 | $-0.30 | 23.33% |
Earnings Summary
For their last quarter, Cellectar Biosciences (CLRB) reported earnings of -$0.40 per share, beating the Zacks Consensus Estimate of $-0.50 per share. This reflects a positive earnings surprise of 20.00%. Look out for CLRB's next earnings release on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 58.9%.
Earnings History
Price & Consensus
Zacks News for CLRB
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
CLRB: What are Zacks experts saying now?
Zacks Private Portfolio Services